← Back to Bills
HR 6222118th CongressFailed / ExpiredHouse

Justice for Victims of COVID Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 19, 2024
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Trade.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Justice for Victims of COVID Act, introduced in the 118th Congress as H.R. 6222, is a health-related legislative proposal aimed at addressing issues related to the COVID-19 pandemic. The bill was referred to the Subcommittee on Trade but did not advance further and ultimately failed or expired. No official summary or full text is available, limiting detailed analysis of its provisions or objectives.

Bottom Line

H.R. 6222 sought to address justice-related concerns stemming from the COVID-19 pandemic but did not progress beyond early committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill is titled 'Justice for Victims of COVID Act' and is categorized under the health policy area.
  • It was introduced in the House of Representatives during the 118th Congress.
  • The latest recorded action was referral to the Subcommittee on Trade on December 17, 2024.
  • The bill ultimately failed or expired without further legislative action.
  • No official summary or full text is publicly available, limiting detailed content analysis.
Who Benefits?

Due to the absence of detailed bill text or summary, it is unclear who specifically would benefit; however, the title suggests potential benefits for individuals or groups affected by COVID-19-related harms or injustices.

Potential Concerns

Without access to the bill's full text or summary, potential concerns cannot be fully identified. General considerations for similar legislation include implementation challenges, funding requirements, jurisdictional authority, and oversight mechanisms.

Political Context

The bill was introduced during the 118th Congress and referred to a subcommittee but did not advance, indicating limited legislative momentum. The health policy area and the focus on COVID-19 reflect ongoing congressional interest in pandemic-related issues.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

If enacted, the bill could have influenced health policy related to COVID-19 victims, potentially affecting healthcare providers, legal systems, and public health agencies. Its failure to pass means these potential effects did not materialize.

GovScope Watchdog Notes

The absence of an official summary and full text restricts transparency and public oversight. The bill's failure to advance highlights the importance of tracking legislative progress to understand which proposals receive consideration and which do not.

Passage Likelihood: LowConfidence: 40%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready